Rational Design, Synthesis, and Evaluation of Nanomolar Type II Dehydroquinase Inhibitors
✍ Scribed by Richard J. Payne; Fabienne Peyrot; Olivier Kerbarh; Andrew D. Abell; Chris Abell
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 641 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1860-7179
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The in silico design, synthesis, and biological evaluation of ten potent type II dehydroquinase inhibitors are described. These compounds contain an anhydroquinate core, incorporated as a mimic of the enolate reaction intermediate. This substructure is attached by a variety of linking units to a terminal phenyl group that binds in an adjacent pocket. Inhibitors were synthesised from (−)‐quinic acid using palladium‐catalysed Stille and carboamidation chemistry. Several inhibitors exhibited nanomolar inhibition constants against type II dehydroquinases from Streptomyces coelicolor and Mycobacterium tuberculosis. These are among the most potent inhibitors of these enzymes reported to date.
📜 SIMILAR VOLUMES
## Abstract Several 3‐heteroaryl analogs of the known dehydroquinase inhibitor (1R,4R,5R)‐1,4,5‐trihydroxy‐2‐cyclohexene‐1‐carboxylic acid (**4**) were synthesized and tested as inhibitors of Helicobacter pylori type II dehydroquinase, the third enzyme of the shikimic acid pathway. All of these com